Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Trends in diabetes].

J Ruiz1, M Egli

  • 1Service d'endocrinologie, diabétologie et métabolisme, CHUV, 1011 Lausanne. juan.ruiz@chuv.ch

Revue Medicale Suisse
|March 4, 2008
PubMed
Summary
This summary is machine-generated.

A meta-analysis linked rosiglitazone to increased heart risks, but its methods were questioned. Intensified treatment of cardiovascular risk factors significantly reduces mortality in type 2 diabetes patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Performance of a flat panel reactor in the continuous culture of microalgae in urban wastewater: prediction from a batch experiment.

Bioresource technology·2012
Same author

Efficacy of intravenous lacosamide as an add-on treatment in refractory status epilepticus: a multicentric prospective study.

Seizure·2012
Same author

[Coagulase-negative Staphylococcus bacteraemia: prognosis factors and influence of antibiotic treatment].

Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia·2012
Same author

The cellular effects of carbon monoxide in the airway.

Current molecular medicine·2012
Same author

Giant cavernous hemangioma in renal graft: a case report.

Transplantation proceedings·2012
Same author

Criterion-related validity of field-based muscular fitness tests in youth.

The Journal of sports medicine and physical fitness·2012
Same journal

Revue medicale suisse·2026
Same journal

Revue medicale suisse·2026
Same journal

Revue medicale suisse·2026
Same journal

Revue medicale suisse·2026
Same journal

Revue medicale suisse·2026
Same journal

[Erythema multiforme : target deciphering].

Revue medicale suisse·2026
See all related articles

Area of Science:

  • Cardiology
  • Endocrinology
  • Clinical Trials

Context:

  • Concerns regarding rosiglitazone's cardiovascular safety in type 2 diabetes treatment.
  • Criticism of a recent meta-analysis on rosiglitazone, highlighting limitations in evidence hierarchy.
  • The 4T study evaluated three insulin strategies for type 2 diabetes management.

Purpose:

  • To critically evaluate the evidence on rosiglitazone's cardiovascular risks.
  • To assess the effectiveness of different insulin strategies in achieving glycemic control in type 2 diabetes.
  • To examine the long-term impact of intensified cardiovascular risk factor management.

Summary:

  • A meta-analysis indicated increased myocardial infarction risk and cardiovascular mortality with rosiglitazone, but its methodology faced scrutiny.

Related Experiment Videos

  • The 4T study demonstrated that only a small proportion of type 2 diabetes patients achieved treatment goals within one year.
  • Post-Steno 2 data confirmed that aggressive management of all cardiovascular risk factors substantially lowers cardiovascular mortality.

    • Impact:

    • Highlights the limitations of meta-analyses in establishing definitive evidence.
    • Underscores the challenges in achieving optimal glycemic control with current insulin strategies for type 2 diabetes.
    • Reinforces the critical importance of comprehensive cardiovascular risk management in reducing long-term mortality for diabetic patients.